Chris Toth

Chris Toth

September 25, 2020
PALO ALTO, Calif., Sept. 14, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced the following leadership appointments, effective October 5, 2020:

Chris Toth, Varian Oncology Systems President, has been appointed to the newly created role of President and Chief Operating Officer;
Kevin O'Reilly, Senior Vice President of Global Operations, will succeed Toth as Senior Vice President and President of Varian Oncology Systems; and Stephanie Foster, Vice President of Revenue Operations, has been named Senior Vice President of Global Supply Chain Operations.

As President and COO, Toth will oversee Varian's business operations, including execution of the Company's fiscal 2021 goals and strategic initiatives. Toth will continue to report to Chief Executive Officer Dow Wilson. In addition, O'Reilly will be focused on executing Varian's proven strategy in Oncology Systems, and Foster will lead all aspects of the Company's integrated supply chain for Oncology Systems.­

"This announcement is a testament to the deep and diverse bench of talented leaders we have at Varian, as well as a reflection of our commitment to realizing our vision and strengthening our support for Varian's customers and their patients," said Wilson. "I'm thrilled to congratulate Chris, Kevin and Stephanie on their expanded leadership roles, and I'm confident that they will ensure our entire team is well positioned to build on Varian's success and accomplish our goals for 2021 and beyond."

Wilson continued, "Chris is an ideal fit for Varian's President and COO, as he is a proven leader whose contributions over the past two decades have been invaluable to the growth of our company – from both a business perspective and a cultural one. In addition to an impressive track record of strategic planning and execution, Chris brings a passion to his work that inspires and motivates our team to advance the fight against cancer. I'm excited to see all that Varian will accomplish under his leadership."

"This is an important moment in Varian's history, and I am honored to work with our talented and agile team to build on our strong momentum," said Toth. "Varian is moving at full speed to achieve our goal of a world without fear of cancer. While we work toward completing a transformational combination with Siemens Healthineers, we're continuing to make impressive progress on our efforts to provide more intelligent solutions, data and insights to deliver world-class cancer care globally. Looking ahead, we don't intend to slow down. Our unwavering focus on helping our customers care for their patients will continue to propel us forward."

About Chris Toth
Chris Toth is an established leader with nearly 20 years of industry experience. Since joining Varian in 2001, he has held multiple executive positions. Most recently, Toth has served as President of Varian Oncology Systems, managing more than $3 billion in revenue and over 7,000 employees worldwide. In this role, he helped return Varian to double-digit growth. Prior to his role as President of Varian Oncology Systems, Toth served as President of Global Commercial and Field Operations, where he was responsible for a global sales strategy and execution across Varian's Oncology and Proton Therapy businesses. Under his leadership, Varian grew its global market share and the Company's Net Promoter Score reached all-time highs.

About Kevin O'Reilly
Kevin O'Reilly is a global executive with over 30 years of experience across multiple industries and geographies. He currently serves as Varian's SVP of Global Operations, overseeing Varian Oncology Systems' global supply chain, revenue and customer support, and managing $3 billion in revenue and over 2,000 employees worldwide. Previously, O'Reilly was President of Asia Pacific, where he tripled Varian's Net Promoter Score and increased revenues and orders faster than the market. Prior to joining Varian in 2009, he held executive positions at RPO, Inc. and Photon Dynamics.

About Stephanie Foster
Stephanie Foster has over 30 years of experience in supply chain, operations and manufacturing in highly complex, regulated industries. In her current role as Vice President of Revenue Operations, Foster oversees contracts, sales and operation planning, logistics, installation services and environmental health and safety. Prior to joining Varian in 2019, she served as Vice President of Supply Chain at Honeywell, where she managed operations for a $4 billion division that manufactured products for the Defense, Space and Aviation industries. Before joining Honeywell, Foster held executive roles at Orbital ATK and Raytheon.

About Varian
At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 10,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight.